Heide, Aurelia Stirnadel-Farrant

Tumor Head, Oncology Outcomes Research

AstraZeneca UK Limited

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Aurelia Stirnadel-Farrant Heide is a Tumor Head in Oncology Outcomes Research at Astra Zeneca, located in the United Kingdom. Her research focuses on real-world treatment patterns and outcomes in various cancers, including hepatocellular carcinoma, gastric cancer, and biliary tract cancers. She also investigates healthcare resource utilization and patient-reported outcomes in conditions such as eosinophilic granulomatosis and systemic lupus erythematosus.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (2)

Farshid Dayyani

University of California, Irvine

UNITED STATES

View details

Andreas Schwarting

Head, Division of Rheumatology and Clinical Immunology, Prof.Dr.

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Heide, Aurelia Stirnadel-Farrant

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Real-world treatment patterns and outcomes in patients with early-stage HCC in the US treated with resection or ablation

RWD157 K2GC: Real-world Treatments and Outcomes Amongst Patients With Resectable Gastric (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States (US)

Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study

Disease Overlap, Healthcare Resource Utilization, and Costs in Patients with Eosinophilic Granulomatosis with Polyangiitis: A REVEAL Sub-study

Anifrolumab Study for Treatment Effectiveness in the Real World (ASTER) among patients with systemic lupus erythematosus: protocol for an international observational effectiveness study

Clinical symptoms, comorbidities, treatment patterns and time to diagnosis in patients with eosinophilic oesophagitis in England: a retrospective cohort study

The Liver Meeting: San Diego, California, Nov 15-19, 2024

Patient-reported symptoms and burden of eosinophilic esophagitis: evidence from real-world clinical practice

The Impact of Systemic Lupus Erythematosus Flares on Clinical and Economic Outcomes: The CHAMOMILE Claims Database Study in Germany

Association Between Elevated Blood Eosinophils and Chronic Kidney Disease Progression: Analyses of a Large United States Electronic Health Records Database

Collaborators (2)

Farshid Dayyani

Andreas Schwarting

Make your next move.